Ignite Creation Date:
2025-12-24 @ 11:16 PM
Ignite Modification Date:
2026-01-02 @ 1:49 AM
Study NCT ID:
NCT07086456
Status:
RECRUITING
Last Update Posted:
2025-07-25
First Post:
2025-07-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination of Concurrent Chemoradiotherapy With Surufatinib and Tislelizumab in Patients With Locally Advanced Non-Small Cell Lung Cancer
Sponsor:
Sun Yat-sen University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-07-20
Start Date Type:
ESTIMATED
Primary Completion Date:
2029-07-19
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-07-19
Completion Date Type:
ESTIMATED
First Submit Date:
2025-07-15
First Submit QC Date:
None
Study First Post Date:
2025-07-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-24
Last Update Post Date:
2025-07-25
Last Update Post Date Type:
ACTUAL